A. Lindblad (Gothenburg, Sweden), H. Tiddens (Rotterdam, Netherlands)
Regional deposition of 99mTc-labelled alpha-1 antitrypsin (AAT) in patients with alpha-1 antitrypsin deficiency and cystic fibrosis (CF) compared with healthy volunteers
M. Wencker, M. Schulte, J. Seitz, G. Klein, T. Meyer (Frankfurt, Gauting, Germany; NC, United States Of America)
|   |
The effect of inhaled steroids on bronchial hyperreactivity, oxidative status, clinical and inflammatory paramerters in patients with cystic fibrosis
Z. S. Uyan, G. Unluguzel, G. Haklar, E. Cakir, S. Oktem, R. Ersu, B. Karadag, F. Karakoc, E. Dagli (Istanbul, Turkey)
| |
Long-term, low-dose azithromycin treatment reduces the prevalence of staphylococcus aureus, but selects for macrolide resistance in Danish CF-patients
C. Hansen, H. Johansen, T. Pressler, H. Niels (Copenhagen, Denmark)
| |
Microbiological audit in cystic fibrosis Romanian children
I. Ciuca Popa, Z. Popa, I. Popa, L. Pop (Timisoara, Romania)
| |
Microbiology of induced sputum vs oropharyngeal culture in cystic fibrosis patients not producers of spontaneous sputum
C. Vazquez, E. López de Santamaría, F. Baranda, A. Gómez, A. Sojo, M. Santiago, B. Gáldiz (Bilbao (Bizkaia), Bilbao, Spain)
| |
Retrospective case review of methicillin-resistant staphylococcus aureus (MRSA) infection in a paediatric shared-care cystic fibrosis clinic
C. Bossley, C. Benwell, C. Pao, G. Ruiz (London, United Kingdom)
| |
Bacterial contamination of PEP masks
B. M. Jakobsson, G. Fessè, G. Hedin, L. Hjelte (Stockholm, Sweden)
| |
Spontaneous release of interferon by peripheral blood mononuclear cells (PBMC) in patients with cystic fibrosis (CF)
T. Bulgakova, T. Kramskaia, E. Boitsova, T. Gembitskaia (Saint-Petersburg, Russian Federation)
| |
Detection of antineutrophil cytoplasmic antibodies (ANCA) and antinuclear antibodies (ANA) in children and adults with cystic fibrosis (CF)
M. M. Filewska, W. Skorupa, J. Kus, A. Pogorzelski, Z. Doniec, B. Broniarek-Samson, U. Demkow (Warsaw, Rabka, Poland)
| |